The FDA approved Apellis’ drug Empaveli for two rare kidney diseases, following strong results from a Phase 3 trial.

The FDA approved pegcetacoplan (EMPAVELI; Apellis Pharmaceuticals) as the first treatment for patients aged 12 and older with the rare, severe kidney diseases C3 glomerulopathy (C3G) and primary ...

Proven efficacy across all three key markers of disease-68% reduction in proteinuria, stabilization of kidney function, and substantial clearance of C3 deposits Broad label includes adults and ...

Lollapolooza 2025's mainstage will be powered entirely by a hybrid battery system, as it was for the first time in 2024.

Car dealers have been told to halt sales of second-hand Citroens after a 'stop-drive' warning was issued amid potentially dangerous airbags.

July 28, 2025) - C3 Metals Inc. (TSXV: CCCM) (OTCQB: CUAUF) ("C3 Metals" or the "Company") is pleased to announce results of a closely spaced soil sampling program completed over a volcanic redbed ...

The rare ‘do not drive’ recall, affecting around 120,000 Citroen vehicles in Britain, was triggered by a deadly airbag fault ...

A MAJOR road used by thousands of Irish drivers is now closed for over two weeks with diversions in place. Fingal County Council has alerted motorists about the temporary closure on ...

Citroen has announced pricing for its new C5 Aircross with the flagship SUV set to start from just over £30,000. The C5 ...